S. Ananth Karumanchi

54.2k total citations · 19 hit papers
367 papers, 38.2k citations indexed

About

S. Ananth Karumanchi is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, S. Ananth Karumanchi has authored 367 papers receiving a total of 38.2k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Obstetrics and Gynecology, 202 papers in Pediatrics, Perinatology and Child Health and 114 papers in Immunology. Recurrent topics in S. Ananth Karumanchi's work include Pregnancy and preeclampsia studies (253 papers), Birth, Development, and Health (166 papers) and Reproductive System and Pregnancy (100 papers). S. Ananth Karumanchi is often cited by papers focused on Pregnancy and preeclampsia studies (253 papers), Birth, Development, and Health (166 papers) and Reproductive System and Pregnancy (100 papers). S. Ananth Karumanchi collaborates with scholars based in United States, Germany and Canada. S. Ananth Karumanchi's co-authors include Ravi Thadhani, Richard J. Levine, Sarosh Rana, Vikas P. Sukhatme, Isaac E. Stillman, Sharon E. Maynard, Franklin H. Epstein, Camille E. Powe, Cong Qian and Joey P. Granger and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

S. Ananth Karumanchi

358 papers receiving 37.4k citations

Hit Papers

Excess placental soluble fms-like tyrosine kinase 1 (sFlt... 2003 2026 2010 2018 2003 2004 2006 2006 2018 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
    2003 3.1k citations Kee-Hak Lim, Towia A. Libermann et al. Journal of Clinical Investigation profile →
  2. Circulating Angiogenic Factors and the Risk of Preeclampsia
    2004 2.7k citations Richard J. Levine, Ravi Thadhani et al. profile →
  3. Soluble endoglin contributes to the pathogenesis of preeclampsia
    2006 1.4k citations Shivalingappa Venkatesha, Chun Sing Lam et al. profile →
  4. Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
    2006 1.4k citations Richard J. Levine, Chun Sing Lam et al. profile →
  5. Hypertensive Disorders of Pregnancy
    2018 1.3k citations Laura A. Magee, S. Ananth Karumanchi et al. Hypertension profile →
  6. Preeclampsia
    2019 1.3k citations Sarosh Rana, S. Ananth Karumanchi et al. profile →
  7. Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans
    2013 786 citations Camille E. Powe, Julia Wenger et al. profile →
  8. Preeclampsia, a Disease of the Maternal Endothelium
    2011 760 citations Camille E. Powe, Richard J. Levine et al. Circulation profile →
  9. Pre-eclampsia: pathogenesis, novel diagnostics and therapies
    2019 741 citations Ravi Thadhani, S. Ananth Karumanchi et al. profile →
  10. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice
    2018 728 citations Laura A. Magee, S. Ananth Karumanchi et al. profile →
  11. Pathogenesis of Preeclampsia
    2010 548 citations Richard J. Levine, S. Ananth Karumanchi et al. profile →
  12. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
    2008 535 citations Richard J. Levine, S. Ananth Karumanchi et al. profile →
  13. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
    2012 491 citations Sarosh Rana, Camille E. Powe et al. Circulation profile →
  14. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice
    2021 456 citations Laura A. Magee, S. Ananth Karumanchi et al. profile →
  15. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
    2011 402 citations Manoj Bhasin, Eliyahu V. Khankin et al. Journal of Clinical Investigation profile →
  16. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection
    2016 398 citations Anders H. Berg, Eliyahu V. Khankin et al. profile →
  17. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
    2021 259 citations S. Ananth Karumanchi, Laura A. Magee et al. Hypertension profile →
  18. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia
    2021 128 citations Stefan Verlohren, S. Ananth Karumanchi et al. profile →
  19. SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
    2024 48 citations Ambart E. Covarrubias, M Yamashita et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ananth Karumanchi United States 94 26.7k 20.0k 11.0k 5.3k 3.5k 367 38.2k
Christopher W.G. Redman United Kingdom 84 19.6k 0.7× 16.3k 0.8× 9.1k 0.8× 5.1k 1.0× 4.0k 1.1× 297 30.7k
Ravi Thadhani United States 84 9.5k 0.4× 8.7k 0.4× 4.0k 0.4× 2.7k 0.5× 2.2k 0.6× 293 30.6k
Philip N. Baker United Kingdom 73 13.1k 0.5× 10.7k 0.5× 3.4k 0.3× 3.0k 0.6× 2.6k 0.7× 522 21.5k
John‏ Kingdom Canada 68 12.0k 0.4× 10.8k 0.5× 2.7k 0.2× 2.2k 0.4× 2.4k 0.7× 378 17.3k
Frank W. Sellke United States 65 4.1k 0.2× 3.0k 0.2× 2.7k 0.2× 5.8k 1.1× 517 0.1× 575 22.7k
Jacob Selhub United States 104 2.5k 0.1× 3.8k 0.2× 679 0.1× 7.0k 1.3× 4.3k 1.2× 382 37.7k
Richard J. Levine United States 48 9.5k 0.4× 7.7k 0.4× 3.4k 0.3× 882 0.2× 1.5k 0.4× 116 12.7k
Kerstin Amann Germany 74 1.1k 0.0× 2.0k 0.1× 4.3k 0.4× 6.7k 1.3× 682 0.2× 584 24.4k
Cuilin Zhang United States 69 8.8k 0.3× 5.5k 0.3× 544 0.0× 2.0k 0.4× 4.1k 1.2× 395 18.5k
Fredrik Granath Sweden 73 1.8k 0.1× 1.8k 0.1× 2.0k 0.2× 1.0k 0.2× 2.1k 0.6× 250 15.9k

Countries citing papers authored by S. Ananth Karumanchi

Since Specialization
Citations

This map shows the geographic impact of S. Ananth Karumanchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ananth Karumanchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ananth Karumanchi more than expected).

Fields of papers citing papers by S. Ananth Karumanchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ananth Karumanchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ananth Karumanchi. The network helps show where S. Ananth Karumanchi may publish in the future.

Co-authorship network of co-authors of S. Ananth Karumanchi

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ananth Karumanchi. A scholar is included among the top collaborators of S. Ananth Karumanchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ananth Karumanchi. S. Ananth Karumanchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karumanchi, S. Ananth, et al.. (2025). Fabrication and Characterization of Highly Porous Gyroid Scaffolds Composed of Deproteinized Bone Mineral. Journal of Functional Biomaterials. 16(4). 119–119.
2.
Gonzalez, Tania L, Yizhou Wang, Chintda Santiskulvong, et al.. (2024). High-throughput mRNA-seq atlas of human placenta shows vast transcriptome remodeling from first to third trimester. Biology of Reproduction. 110(5). 936–949. 5 indexed citations
3.
Jacobs, Christopher, et al.. (2023). Hypoxia-inducible factor 1 signaling drives placental aging and can provoke preterm labor. eLife. 12. 14 indexed citations
4.
Accortt, Eynav Elgavish, James Mirocha, Dongsheng Zhang, et al.. (2023). Perinatal mood and anxiety disorders: biomarker discovery using plasma proteomics. American Journal of Obstetrics and Gynecology. 229(2). 166.e1–166.e16. 12 indexed citations
5.
Berg, Anders H., M Yamashita, Chengqun Huang, et al.. (2022). Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway. Journal of Clinical Investigation. 132(20). 14 indexed citations
6.
Berg, Anders H., Agnes S. Lo, Sherri‐Ann M. Burnett‐Bowie, et al.. (2021). Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay. PLoS ONE. 16(7). e0254158–e0254158. 1 indexed citations
7.
Adnan, Wan Ahmad Hafiz Wan Md, Camille E. Powe, Jeffrey L. Ecker, et al.. (2018). Risk of Preeclampsia and Pregnancy Complications in Women With a History of Acute Kidney Injury. Hypertension. 72(2). 451–459. 33 indexed citations
8.
Prete, Alessandro, Agnes S. Lo, Peter M. Sadow, et al.. (2018). Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis. Clinical Cancer Research. 24(23). 6078–6097. 46 indexed citations
9.
Hooft, Janneke van ’t, Chris Gale, Ray Fitzpatrick, et al.. (2017). Developing a pre-eclampsia core outcome set. Round 1 results: 283 healthcare professionals, 41 researchers and 112 patients from 55 countries participated. British Journal of Obstetrics and Gynaecology. 124. 151–152. 1 indexed citations
10.
Falk, Roni T., Annetine Staff, Gary Bradwin, S. Ananth Karumanchi, & Rebecca Troisi. (2016). A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Causes & Control. 27(8). 1009–1017. 5 indexed citations
11.
Khankin, Eliyahu V., Robert M. Blanton, Mark Aronovitz, et al.. (2015). Exposure to Experimental Preeclampsia in Mice Enhances the Vascular Response to Future Injury. Hypertension. 65(4). 863–870. 65 indexed citations
12.
Karumanchi, S. Ananth, et al.. (2015). Hydrogen sulfide. Current Opinion in Nephrology & Hypertension. 24(2). 170–176. 53 indexed citations
13.
Venditti, Carolina, Richard Casselman, Iain D. Young, S. Ananth Karumanchi, & Graeme N. Smith. (2014). Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model. PLoS ONE. 9(9). e106502–e106502. 38 indexed citations
14.
Rana, Sarosh, S. Ananth Karumanchi, & Marshall D. Lindheimer. (2013). Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension. 63(2). 198–202. 86 indexed citations
15.
McCurley, Amy, et al.. (2013). Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors. Arteriosclerosis Thrombosis and Vascular Biology. 34(2). 355–364. 109 indexed citations
16.
Cohen, Allison, Julia Wenger, Tamarra James‐Todd, et al.. (2013). The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertension in Pregnancy. 33(1). 81–92. 45 indexed citations
17.
Rana, Sarosh, Camille E. Powe, Saira Salahuddin, et al.. (2012). Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation. 125(7). 911–919. 491 indexed citations breakdown →
18.
Khankin, Eliyahu V., Simone Schüller, Geneviève Escher, et al.. (2010). Regulation of Placental Growth by Aldosterone and Cortisol. Endocrinology. 152(1). 263–271. 72 indexed citations
19.
Qazi, Umair, Chun Sing Lam, S. Ananth Karumanchi, & Michelle Petri. (2008). Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.. PubMed. 35(4). 631–4. 44 indexed citations
20.
Rana, Sarosh, et al.. (2007). Cytomegalovirus-Induced Mirror Syndrome Associated With Elevated Levels of Circulating Antiangiogenic Factors. Obstetrics and Gynecology. 109(2). 549–552. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher W.G. Redman Breakdown of academic impact, for papers by Ravi Thadhani Breakdown of academic impact, for papers by Philip N. Baker Breakdown of academic impact, for papers by John‏ Kingdom Breakdown of academic impact, for papers by Frank W. Sellke Breakdown of academic impact, for papers by Jacob Selhub Breakdown of academic impact, for papers by Richard J. Levine Breakdown of academic impact, for papers by Kerstin Amann Breakdown of academic impact, for papers by Cuilin Zhang Breakdown of academic impact, for papers by Fredrik Granath
Rankless by CCL
2026